Please login to the form below

Not currently logged in
Email:
Password:

Epanova

This page shows the latest Epanova news and features for those working in and with pharma, biotech and healthcare.

FDA approves AZ’s fish oil drug

FDA approves AZ’s fish oil drug

FDA approves AZ’ s fish oil drug. Epanova gets green light to reduce high levels of fat in the blood. ... Epanova is one of several pipeline-boosting drugs acquired by AZ over the past couple of years since Pascal Soriot took over as CEO.

Latest news

  • Teva launches first generic of GSK's Lovaza in US Teva launches first generic of GSK's Lovaza in US

    Also affected is AstraZeneca, which filed for approval of its own triglyceride-lowering drug Epanova last year. ... AZ acquired Epanova along with developer Omthera Pharmaceuticals in July 2013 in a $443m deal.

  • FDA to review AZ's fish oil drug Epanova FDA to review AZ's fish oil drug Epanova

    FDA to review AZ's fish oil drug Epanova. Hypertriglyceridaemia treatment acquired as part of Omthera takeover. ... The US Food and Drug Administration (FDA) will assess Epanova for use in the treatment of patients with severe hypertriglyceridaemia –

  • AZ target Omthera files blood fat drug in US

    AZ target Omthera files blood fat drug in US. FDA submission for Epanova in severe hypertriglyceridemia. ... Omthera Pharmaceuticals said yesterday it had submitted its drug Epanova for US approval in the treatment of patients with high levels of the

  • AstraZeneca offers $443m to buy Omthera AstraZeneca offers $443m to buy Omthera

    If finalised, AZ will take control of the drug candidate Epanova, which has completed phase III testing and is ready for regulatory submissions to treat elevated blood triglycerides. ... Epanova is an omega-3 free fatty acid composition that has been

More from news
Approximately 4 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during May 2014 Pharma deals during May 2014

    One year ago AstraZeneca acquired Omthera. On May 7 Epanova, a soft gelation capsule containing Omega-3, was approved by the FDA as an adjunct to diet to reduce triglyceride levels

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics